92 related articles for article (PubMed ID: 28286014)
21. Activation of Endogenous Cardiac Stem Cells by Apelin-13 in Infarcted Rat Heart.
Zhang NK; Cao Y; Zhu ZM; Zheng N; Wang L; Xu XH; Gao LR
Cell Transplant; 2016; 25(9):1645-1652. PubMed ID: 26924778
[TBL] [Abstract][Full Text] [Related]
22. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.
Makkar RR; Price MJ; Lill M; Frantzen M; Takizawa K; Kleisli T; Zheng J; Kar S; McClelan R; Miyamota T; Bick-Forrester J; Fishbein MC; Shah PK; Forrester JS; Sharifi B; Chen PS; Qayyum M
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):225-33. PubMed ID: 16382259
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell therapy associated with endurance exercise training: Effects on the structural and functional remodeling of infarcted rat hearts.
Lavorato VN; Del Carlo RJ; da Cunha DN; Okano BS; Belfort FG; de Freitas JS; da Mota Gde F; Quintão-Júnior JF; Silame-Gomes LH; Drummond FR; Carneiro-Júnior MA; de Oliveira EM; Monteiro BS; Prímola-Gomes TN; Natali AJ
J Mol Cell Cardiol; 2016 Jan; 90():111-9. PubMed ID: 26705058
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
25. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic transcriptional profile remains activated in late remodeled left ventricle after myocardial infarction in swine infarcted hearts with preserved ejection fraction.
Prescimone T; Lionetti V; Cabiati M; Caselli C; Aquaro GD; Matteucci M; Del Ry S; Giannessi D
Pharmacol Res; 2013 Apr; 70(1):41-9. PubMed ID: 23295943
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
29. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
30. Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post-Myocardial Infarction Repair by Regulating Angiogenesis.
Fan D; Takawale A; Shen M; Wang W; Wang X; Basu R; Oudit GY; Kassiri Z
Circ Heart Fail; 2015 Sep; 8(5):970-9. PubMed ID: 26136458
[TBL] [Abstract][Full Text] [Related]
31. Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
Rathinavel A; Sankar J; Mohammed Sadullah SS; Niranjali Devaraj S
Fundam Clin Pharmacol; 2018 Feb; 32(1):51-59. PubMed ID: 29059499
[TBL] [Abstract][Full Text] [Related]
32. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts.
Li Q; Li N; Cui HH; Tian XQ; Jin C; Chen GH; Yang YJ
Exp Physiol; 2017 Apr; 102(4):422-435. PubMed ID: 28150462
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of myocardial tissue from the border zone during early stage post-infarct remodelling in rats.
Xiang F; Shi Z; Guo X; Qiu Z; Chen X; Huang F; Sha J; Chen X
Eur J Heart Fail; 2011 Mar; 13(3):254-63. PubMed ID: 21148594
[TBL] [Abstract][Full Text] [Related]
34. Epicardial placement of human placental membrane protects from heart injury in a swine model of myocardial infarction.
Skaria RS; Lopez-Pier MA; Kathuria BS; Leber CJ; Langlais PR; Aras SG; Khalpey ZI; Hitscherich PG; Chnari E; Long M; Churko JM; Runyan RB; Konhilas JP
Physiol Rep; 2023 Oct; 11(20):e15838. PubMed ID: 37849042
[TBL] [Abstract][Full Text] [Related]
35. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
37. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
38. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Chang WT; Cheng JT; Chen ZC
Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of Repolarization and Cell-Cell Variability of Cardiomyocyte Remodeling Within the Myocardial Infarction Border Zone Contribute to Arrhythmia Susceptibility.
Amoni M; Vermoortele D; Ekhteraei-Tousi S; Doñate Puertas R; Gilbert G; Youness M; Thienpont B; Willems R; Roderick HL; Claus P; Sipido KR
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011677. PubMed ID: 37128895
[TBL] [Abstract][Full Text] [Related]
40. Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction.
Park JR; Ahn JH; Jung MH; Koh JS; Park Y; Hwang SJ; Jeong YH; Kwak CH; Lee YS; Seo HG; Kim JH; Hwang JY
PLoS One; 2016; 11(2):e0148510. PubMed ID: 26862756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
